As of Oct 20
| -0.20 / -0.44%|
The 15 analysts offering 12-month price forecasts for DexCom Inc have a median target of 69.00, with a high estimate of 100.00 and a low estimate of 57.00. The median estimate represents a +54.09% increase from the last price of 44.78.
The current consensus among 18 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.